8-Bromoguanosine 3,5-cyclic monophosphate sodium salt, >=98% (HPLC), powder

Code: b1381-10mg D2-231

Not available outside of the UK & Ireland.

Application

8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt has been used: as a cyclic guanosine 3’;:5’;-monophosphate (cGMP) agonist in the...


read more

Your Price
£97.50 10MG

Not available outside of the UK & Ireland.

Application

8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt has been used: as a cyclic guanosine 3’;:5’;-monophosphate (cGMP) agonist in the collapse assay in retinal ganglion axons(10) as a component of reaction buffer in in vitro kinase activity assay of recombinant protein kinase (PKG)(11) as a cyclic nucleotide analog for the induction of cyclic nucleotide-gated channel (CNGA and CNGC) expression in human embryonic kidney cells(12)

Biochem/physiol Actions

Cell-permeable cGMP analog having greater resistance to hydrolysis by phosphodiesterases than cGMP. Activates cGMP-dependent protein kinase. Slows or inhibits the intracellular calcium oscillations of tracheal smooth muscle cells in response to acetylcholine. Reported to mimic the effect of nitric oxide generating drugs.

8-Bromoguanosine 3′,5′-cyclic monophosphate has greater resistance to hydrolysis by phosphodiesterases than cGMP. Activates cGMP-dependent protein kinase. It slows or inhibits the intracellular calcium oscillations of tracheal smooth muscle cells in response to acetylcholine. 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt mimics the effect of nitric oxide generating drugs. It modulates circadian rhythms and increases optic nerve impulses. In the eye 8-Bromoguanosine 3′,5′-cyclic monophosphate may favour transduction of non-R-type photoreceptors.

Features and Benefits

This compound is featured on the PKA & PKG page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

General description

8-Bromoguanosine 3′,5′-cyclic monophosphate is a cell-permeable cGMP analog of cyclic guanosine 3′:5′-monophosphate (cGMP). It is a lipid-soluble analog used in cGMP based contraction studies in cardiomyocytes.

Packaging

10 mg in glass bottle

25, 100 mg in poly bottle

assay≥98% (HPLC)
formpowder
InChI keyZJRFCXHKYQVNFK-YEOHUATISA-M
InChI1S/C10H11BrN5O7P.Na/c11-9-13-3-6(14-10(12)15-7(3)18)16(9)8-4(17)5-2(22-8)1-21-24(19,20)23-5;/h2,4-5,8,17H,1H2,(H,19,20)(H3,12,14,15,18);/q;+1/p-1/t2-,4-,5-,8-;/m1./s1
Quality Level200
SMILES string[Na+].NC1=Nc2c(nc(Br)n2[C@@H]3O[C@@H]4COP([O-])(=O)O[C@H]4[C@H]3O)C(=O)N1
solubilityH2O: 50 mg/mL
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
B1381-100MG
Unit:100MG
List Price: £619.00
Source:List Price
ADD
B1381-25MG
Unit:25MG
List Price: £204.00
Source:List Price
ADD
Cas Number51116-01-9
This product has met the following criteria: